ClinConnect ClinConnect Logo
Search / Trial NCT06980233

Reentry Assist (R-Assist)

Launched by MEANINGFUL MEASUREMENT, INC · May 12, 2025

Trial Information

Current as of July 25, 2025

Not yet recruiting

Keywords

Substance Use Disorder Mental Health Criminal Legal Involvement

ClinConnect Summary

The Reentry Assist (R-Assist) trial is focused on helping individuals who are recovering from substance use disorders and mental health issues after being released from jail. This program will test a mobile health app designed to support these individuals during their recovery process. The goal is to see how well this app can assist people in managing their challenges as they reintegrate into the community.

To participate in this trial, individuals must have been released from a Massachusetts jail within the last 150 days and own a smartphone. They should also have both a substance use disorder and a mental health disorder, such as depression or anxiety. Participants will be asked to consent to using the app and to allow researchers to observe their use of it, as well as record interviews and focus groups. It's important to note that those who are currently at risk of harming themselves or others, or those who cannot give informed consent, will not be eligible for this study. Overall, participants can expect to engage with the app and share their experiences to help improve support for others in similar situations.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Have been released from the participating jail within the past 150 days
  • Own a smartphone (Android or iOS; 90% met this criterion in our prior studies)
  • Have COD: any substance use disorder (we will allow poly-substance use disorders) and a co-occurring mental health disorder (depression, anxiety, trauma related disorders, bipolar, and/or schizophrenia)
  • Consent to R-Assist app use observation and e-tracking
  • Consent to audio recording during interviews and focus groups.
  • Exclusion Criteria:
  • Acutely suicidal, homicidal, or psychotic
  • Unable to provide informed consent
  • Individuals released with monitoring devices or individuals involved in drug treatment courts

About Meaningful Measurement, Inc

Meaningful Measurement, Inc. is a pioneering clinical trial sponsor dedicated to advancing healthcare through innovative measurement solutions. With a focus on enhancing patient outcomes and streamlining clinical research processes, the company leverages cutting-edge technologies and methodologies to deliver accurate and reliable data. By fostering collaborations with healthcare organizations, researchers, and regulatory bodies, Meaningful Measurement, Inc. aims to facilitate the development of effective therapies and interventions, ultimately contributing to improved health and well-being across diverse populations. Their commitment to excellence and integrity positions them as a trusted partner in the clinical research landscape.

Locations

Patients applied

0 patients applied

Trial Officials

David Smelson, PsyD

Principal Investigator

University of Massachusetts Chan Medical School

Donna Surges Tatum, PhD

Principal Investigator

Meaningful Measurement, LLC

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported